levocarnitine

FDA Drug Profile — CARNITOR, levocarnitine, Carnitor, Carnitor SF

levocarnitine is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including CARNITOR, levocarnitine, Carnitor. Available dosage forms: tablet, injection, solution, powder, solution.

Drug details

Generic Name
levocarnitine
Brand Names
CARNITOR, levocarnitine, Carnitor, Carnitor SF
Application Number
NDA018948
Sponsor
Leadiant Biosciences, Inc.
NDC Codes
8
Dosage Forms
TABLET, INJECTION, SOLUTION, POWDER, SOLUTION
Routes
ORAL, INTRAVENOUS
Active Ingredients
LEVOCARNITINE

Indications and Usage

INDICATIONS AND USAGE For the acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency. For the prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis.

Warnings

WARNINGS Hypersensitivity Reactions Serious hypersensitivity reactions, including anaphylaxis, laryngeal edema, and bronchospasm have been reported following levocarnitine injection administration, mostly in patients with end stage renal disease who are undergoing dialysis. Some reactions occurred within minutes after intravenous administration of levocarnitine injection. If a severe hypersensitivity reaction occurs, discontinue levocarnitine injection treatment and initiate appropriate medical treatment. Consider the risks and benefits of re-administering levocarnitine injection to individual patients following a severe reaction. If the decision is made to re-administer the product, monitor patients for a reoccurrence of signs and symptoms of a severe hypersensitivity reaction.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.